Christian Stevns Hansen

Postdoc, researcher, PhD, MD
Complications Research

Contact

E-mail: Chan0583@regionh.dk
Phone: +45 61 67 16 18



Research area

  • Diabetic autonomic and sensimortor neuropathy. New risk markers for early signs of development of neuropathy.
  • Trials of different treatment modalities to prevent or delay progression of diabetic neuropahty.
  • Investigation of the association between neuropathy and complications  eg. brainfunction, foot complication and heart disease.

Current research

Whitehall II study

Aim: The association between autonomic function and inflammatory markers, beta cell function and cardiovascular disease.
Partners: University City College London, Center of diabetes research, Düsseldorf university.

Rubinaut

Aim: The reversibility of autonomic and peripheral neuropathy in type 1 diabetes patents.
Partners: NovoNordisk Foundation, Joslin Diabetes Center (USA), University Medical Center Groningen (Holland), Folkhälsan Helsinki (Finland).

CIMT-study

Aim: The effect of metformin on peripheral and autonomic neuropathy.
Partners: dept. endocrinology. Herlev Hospital, the research unit at  Hillerød Hospital.

The young study

Aim: Prevalence of neuropathy in young type 1 diabetes patients and risk factors hereto.
Partners: dept. endocrinology Herlev Hospital Heidelberg University hospital.  

Metformin and neuropati

Aim: Acute effect on markers of autonomic neuropathy in type 2 diabetes patients.
Partners:  Center for diabetes research Gentofte Hospital.

Diabetes and neurovascular coupling

Aim: investigating the association between autonomic dysfunction and brain function.
Partners: NEXs Copenhagen University, Aalborg University.

Diabetic neuropathy and exercise

Aim: Investigate the safety and efficacy of exercise in type 1 diabetes patients with autonomic  neuropathy.
Partners: Shefield University Hospital, Dept. of research Hillerød Hospital, Steno Diabetes Center Århus.

Diabetic gastropareses and neuropathy

Aim: Investigating the association between gastropareses and signs of neuropathy in the gastrointestinal mucosa and sign of neuropathy and gastrointestinal function.
Testing the efficacy of a novel surgical treatment method for gastroparesis (G-POEM).
Partners: Center for diabetes research Gentofte Hospital, Dept. of nuclear medicine Rigshospitalet, Dept. of Surgery, Hvidovre Hospital.

Exploring novel risk markers and potential treatment targets for neuropathic pain in type 1 diabetes

Aim: To investigate pathological changes to nerve fibres in skin biopies in patients with painful neuropathy and type 1 diabetes.
Partners: Steno Diabetes Center Aarhus and Odense, Denmark. Heidelberg University Hospital.

Genetic risk factors for diabetic neuropathy in Greenland and Denmark

Aim: To investigate new genetic risk factors for diabetic neuropathy in Greenland and Denmark.
Partners: Steno Diabetes Center Aarhus. Metabolisme center, Panum, Denmark.

New refference values for cardiovascular autonomic neuropathy (CAN)

Aim: Generate new reference values for CAN based on a healthy Danish cohort.
Partners: Steno Diabetes Center Aarhus og Sealand. Lolland-Falster study group.

Probiotiful-study

Aim: To study the efficacy of treatment with probiotics on diabetic nephropathy.
Partners: DSM, Copenhagen Biocare, Metabolisme Center, Panum.


Responsible editor